Company intelligence / Profile preview
Lipidio Pharmaceuticals
San Diego, California, United Stateslipidiopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
GDD3898 is a clinical-stage Phase 2 topical small molecule drug candidate with existing efficacy and human safety data; Lipidio is conducting new clinical studies for multiple indications including obesity, sebaceous hyperplasia, acne, and NASH.
- Therapeutic areas
- EndocrinologyDermatologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Lipidio Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipidio Pharmaceuticals.